Suppr超能文献

[用于角膜和结膜原位癌放射治疗的钌105施源器]

[Ruthenium 105-applicator for radiation treatment of carcinoma in situ of the cornea and conjunctiva].

作者信息

Häberle H, Pham D T, Scholman H J, Wollensak J

机构信息

Augenklinik, Klinikum Rudolf Virchow, Humboldt-Universität Berlin.

出版信息

Ophthalmologe. 1995 Dec;92(6):866-9.

PMID:8563440
Abstract

Intraepithelial neoplasias of cornea and conjunctiva are rare epibulbar tumors. In this report we describe the cases of two male patients, aged 37 and 80 years, each with histologically confirmed carcinoma in situ of the cornea and conjunctiva affecting one eye. Both carcinomas recurred in spite of complete surgical excision of the tumor. One patient had additional cryotherapy. Both recurrences were treated once with radiotherapy using a conventional 106Ru applicator. The applicator was fixed to the sclera adjacent to the corneal limbus. A 100 Gy radiation dose was delivered with 2mm tissue penetration. No complications were observed post-operatively. The 2-year follow-up examinations showed no further recurrences. Brachytherapy with 106 Ru applicator was thus effective in achieving local tumor control. These findings suggest brachytherapy of the anterior segment using the 106 Ru applicator as the first-line procedure in the early stages of epithelia dysplasia or carcinoma in situ.

摘要

角膜和结膜上皮内瘤变是罕见的眼球表面肿瘤。在本报告中,我们描述了两名男性患者的病例,年龄分别为37岁和80岁,均经组织学确诊为单眼角膜和结膜原位癌。尽管肿瘤已完全手术切除,但两种癌均复发。其中一名患者还接受了冷冻疗法。两次复发均使用传统的106钌敷贴器进行了一次放射治疗。敷贴器固定在角膜缘附近的巩膜上。以2毫米的组织穿透深度给予100戈瑞的辐射剂量。术后未观察到并发症。两年的随访检查显示未进一步复发。因此,使用106钌敷贴器进行近距离放射治疗在实现局部肿瘤控制方面是有效的。这些发现表明,在上皮发育异常或原位癌的早期阶段,使用106钌敷贴器对前段进行近距离放射治疗可作为一线治疗方法。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验